Methyl 4-methoxysalicylate → HCID 68530524, compound
Reaction equation
C(O[N:6]1[CH2:11][CH2:10][CH:9]([O:12][C:13]2[CH:22]=[C:21]([O:23][CH3:24])[CH:20]=[CH:19][C:14]=2[C:15]([O:17][CH3:18])=[O:16])[CH2:8][C:7]1=C=O)(C)(C)C.OC1C=C(OC)C=CC=1C(OC)=O.OC1CCN([C:47]([O:49][C:50]([CH3:53])([CH3:52])[CH3:51])=[O:48])CC1>>[C:50]([O:49][C:47]([N:6]1[CH2:7][CH2:8][CH:9]([O:12][C:13]2[CH:22]=[C:21]([O:23][CH3:24])[CH:20]=[CH:19][C:14]=2[C:15]([O:17][CH3:18])=[O:16])[CH2:10][CH2:11]1)=[O:48])([CH3:53])([CH3:52])[CH3:51]Participants
4
Procedure
Using a procedure similar to that used in Example 21-C, methyl 2-(1-tert-butoxy-carbonylpiperidin-4-yloxy)-4-methoxybenzoate (10.38 g, 71%) was prepared from methyl 2-hydroxy-4-methoxybenzoate and 4-hydroxy-1-tert-butoxycarbonylpiperidine.
Sources & evidence
- ORD record
- ord-ca03b1a247d143f98281b8267208c846
- Source dataset
- uspto-grants-2010_04
- Patent number
- US07700628B2
Reaction notes
Loading…